Skip to main content
SpringerLink
Log in

Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

In normal subjects growth hormone (GH) and insulin-like growth factor-I (IGF-I) have opposing effects on glucose metabolism. Active acromegaly is associated with insulin resistance (IR) and glucose intolerance although both GH and IGF-I are elevated. Our objective was to compare whether GH or IGF-I correlates more closely with IR and glucose intolerance in acromegaly. Basal serum IGF-I and GH, glucose and insulin during an oral glucose tolerance test were measured in 70 normoglycemic and 44 hyperglycemic acromegalic patients (21 impaired fasting glucose, 11 impaired glucose tolerance and 12 diabetes mellitus) according to American Diabetes Association criteria. 55 patients were assessed before any treatment for acromegaly and 59 after surgery and/or radiotherapy (15 patients had normal IGF-I after treatment). Patients treated with somatostatin analogs, GH-receptor antagonists or antidiabetic drugs were excluded. IR was assessed by various basal and stimulated indices. Homeostatic Model Assessment 2-Insulin Resistance (HOMA2-IR) index correlated more closely with IGF-I (r = 0.65, p < 0.0001) than nadir (r = 0.23, p = 0.008) or random GH (r = 0.26, p = 0.002). HOMA2-IR correlated better with IGF-I than nadir or random GH also in normoglycemic (n = 70; r = 0.74, p < 0.0001 vs. r = 0.36, p = 0.001 vs. r = 0.39, p < 0.001) and hyperglycemic patients (n = 44; r = 0.54, p = 0.0002 vs. r = 0.09, p = 0.4 vs. r = 0.14, p = 0.26). In multivariate logistic regression analysis IGF-I but not GH was a significant risk factor for glucose intolerance after adjusting for age, sex, weight and acromegaly duration (OR = 1.56, p = 0.01). In acromegaly IGF-I correlates more closely than GH with IR. IGF-I levels but not GH are associated with glucose intolerance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vazquez JA, Zamora J, Albareda M, Gilabert M (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 151:439–446

    Article  PubMed  CAS  Google Scholar 

  2. Fieffe S, Morange I, Petrossians P, Chanson P, Rohmer V, Cortet C, Borson-Chazot F, Brue T, Delemer B (2011) Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. Eur J Endocrinol 164:877–884

    Article  PubMed  CAS  Google Scholar 

  3. Bex M, Abs R, T’Sjoen G, Mockel J, Velkeniers B, Muermans K, Maiter D (2007) AcroBel—the Belgian registry on acromegaly: a survey of the ‘real-life’ outcome in 418 acromegalic subjects. Eur J Endocrinol 157:399–409

    Article  PubMed  CAS  Google Scholar 

  4. Espinosa-de-Los-Monteros AL, Gonzalez B, Vargas G, Sosa E, Mercado M (2010) Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism. Pituitary 14:231–235

    Article  Google Scholar 

  5. Krag MB, Gormsen LC, Guo Z, Christiansen JS, Jensen MD, Nielsen S, Jorgensen JO (2007) Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. Am J Physiol Endocrinol Metab 292:E920–E927

    Article  PubMed  CAS  Google Scholar 

  6. Hoybye C, Chandramouli V, Efendic S, Hulting AL, Landau BR, Schumann WC, Wajngot A (2008) Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery. Horm Metab Res 40:498–501

    Article  PubMed  CAS  Google Scholar 

  7. Kerr D, Tamborlane WV, Rife F, Sherwin RS (1993) Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin. J Clin Invest 91:141–147

    Article  PubMed  CAS  Google Scholar 

  8. Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA (2002) Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects. Am J Physiol Endocrinol Metab 282:E1360–E1368

    PubMed  CAS  Google Scholar 

  9. Benyoucef S, Surinya KH, Hadaschik D, Siddle K (2007) Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation. Biochem J 403:603–613

    Article  PubMed  CAS  Google Scholar 

  10. O’Connell T, Clemmons DR (2002) IGF-I/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms. J Clin Endocrinol Metab 87:4356–4360

    Article  PubMed  Google Scholar 

  11. Laron Z (1999) The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome. J Clin Endocrinol Metab 84:4397–4404

    Article  PubMed  CAS  Google Scholar 

  12. Moller N, Schmitz O, Joorgensen JO, Astrup J, Bak JF, Christensen SE, Alberti KG, Weeke J (1992) Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab 74:1012–1019

    Article  PubMed  CAS  Google Scholar 

  13. Kasayama S, Otsuki M, Takagi M, Saito H, Sumitani S, Kouhara H, Koga M, Saitoh Y, Ohnishi T, Arita N (2000) Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin Endocrinol (Oxf) 52:549–555

    Article  CAS  Google Scholar 

  14. Coculescu M, Niculescu D, Lichiardopol R, Purice M (2007) Insulin resistance and insulin secretion in non-diabetic acromegalic patients. Exp Clin Endocrinol Diabetes 115:308–316

    Article  PubMed  CAS  Google Scholar 

  15. Hopkins KD, Holdaway IM (1992) Insulin secretion and insulin-like growth factor-I levels in active and controlled acromegaly. Clin Endocrinol (Oxf) 36:53–57

    Article  CAS  Google Scholar 

  16. Puder JJ, Nilavar S, Post KD, Freda PU (2005) Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly. J Clin Endocrinol Metab 90:1972–1978

    Article  PubMed  CAS  Google Scholar 

  17. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S69

    Article  Google Scholar 

  18. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141–3148

    Article  PubMed  CAS  Google Scholar 

  19. Williams EJ (1959) The comparison of regression variables. J R Stat Soc Ser B (Methodol) 21:396–399

    Google Scholar 

  20. Kinoshita Y, Fujii H, Takeshita A, Taguchi M, Miyakawa M, Oyama K, Yamada S, Takeuchi Y (2011) Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic {beta}-cell function is preserved. Eur J Endocrinol 164:467–473

    Article  PubMed  CAS  Google Scholar 

  21. Ferrara CM, Goldberg AP (2001) Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance. Diabetes Care 24:245–249

    Article  PubMed  CAS  Google Scholar 

  22. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, Tahara H, Koyama H, Shoji T, Inaba M, Nishizawa Y (2004) Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. J Clin Endocrinol Metab 89:1481–1484

    Article  PubMed  CAS  Google Scholar 

  23. Freda PU (2009) Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clin Endocrinol (Oxf) 71:166–170

    Article  CAS  Google Scholar 

  24. Alexopoulou O, Bex M, Abs R, T’Sjoen G, Velkeniers B, Maiter D (2008) Divergence between growth hormone and insulin-like growth factor-i concentrations in the follow-up of acromegaly. J Clin Endocrinol Metab 93:1324–1330

    Article  PubMed  CAS  Google Scholar 

  25. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R (2009) Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 30:586–623

    Article  PubMed  CAS  Google Scholar 

  26. Modan-Moses D, Janicot M, McLenithan JC, Lane MD, Casella SJ (1998) Expression and function of insulin/insulin-like growth factor I hybrid receptors during differentiation of 3T3-L1 preadipocytes. Biochem J 333(Pt 3):825–831

    PubMed  CAS  Google Scholar 

  27. Guler HP, Zapf J, Froesch ER (1987) Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 317:137–140

    Article  PubMed  CAS  Google Scholar 

  28. Yakar S, Setser J, Zhao H, Stannard B, Haluzik M, Glatt V, Bouxsein ML, Kopchick JJ, LeRoith D (2004) Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest 113:96–105

    PubMed  CAS  Google Scholar 

  29. Frystyk J, Ritzel RA, Maubach J, Busing M, Luck R, Klempnauer J, Schmiegel W, Nauck MA (2008) Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous versus systemic-venous graft drainage: impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-I axis. J Clin Endocrinol Metab 93:1758–1766

    Article  PubMed  CAS  Google Scholar 

  30. Ionescu-Tirgoviste I (2011) Insulin resistance—what is myth and what is reality? Acta Endocrinologica (Buc) 7:123–146

    Article  Google Scholar 

  31. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191–2192

    Article  PubMed  CAS  Google Scholar 

  32. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

    Dan Niculescu & Mihail Coculescu

  2. Department of Nuclear Medicine, C. I. Parhon National Institute of Endocrinology, Bucharest, Romania

    Mariana Purice

Authors
  1. Dan Niculescu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mariana Purice
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mihail Coculescu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mihail Coculescu.

Additional information

Dan Niculescu and Mihail Coculescu contributed equally to this article.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Niculescu, D., Purice, M. & Coculescu, M. Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly. Pituitary 16, 168–174 (2013). https://doi.org/10.1007/s11102-012-0396-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-012-0396-6

Keywords

Search

Navigation